Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
7.97
-0.06 (-0.75%)
At close: Mar 12, 2026, 4:00 PM EDT
7.85
-0.12 (-1.51%)
Pre-market: Mar 13, 2026, 7:44 AM EDT

Grifols Revenue

In the year 2025, Grifols had annual revenue of 1.23B EUR, down -79.02%.

Revenue (ttm)
1.23B EUR
Revenue Growth
-79.02%
P/S Ratio
0.74
Revenue / Employee
51,765 EUR
Employees
23,737
Market Cap
6.57B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.23B-4.63B-79.02%
Dec 31, 20225.86B517.88M9.70%
Dec 31, 20205.34B241.35M4.73%
Dec 31, 20195.10B2.36B85.97%
Dec 31, 20132.74B120.79M4.61%
Dec 31, 20122.62B1.63B164.55%
Dec 31, 2010990.73M77.54M8.49%
Dec 31, 2009913.19M98.88M12.14%
Dec 31, 2008814.31M111.02M15.79%
Dec 31, 2007703.29M54.87M8.46%
Dec 31, 2006648.42M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Merck & Co.65.01B
Pfizer62.58B
Sanofi54.85B
Novo Nordisk48.59B
Bristol-Myers Squibb Company48.19B
GSK plc43.97B
Amgen36.75B
Gilead Sciences29.44B
Revenue Rankings